{"DataElement":{"publicId":"6572598","version":"1","preferredName":"Differentiated Thyroid Cancer AJCC Edition 8 Clinical Regional Lymph Node N Category","preferredDefinition":"Extent of the regional lymph node involvement for differentiated thyroid carcinoma based on evidence obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"DTC_AJC8_CLN_N_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6572580","version":"1","preferredName":"Differentiated Thyroid Gland Carcinoma Clinical N Category","preferredDefinition":"An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"3461579v1.0:2428496v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"3461579","version":"1","preferredName":"Differentiated Thyroid Gland Carcinoma","preferredDefinition":"An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma. (NCI05)","longName":"C7153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Differentiated Thyroid Gland Carcinoma","conceptCode":"C7153","definition":"An adenocarcinoma that arises from the thyroid gland and shows extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary or follicular carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C02DD092-1787-CCAB-E040-BB89AD430207","latestVersionIndicator":"Yes","beginDate":"2012-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-16","modifiedBy":"ONEDATA","dateModified":"2012-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BC0852D-4973-7E1B-E053-F662850A8E0C","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"TAYLORT","dateModified":"2020-04-03","changeDescription":"4/3/20 tmt released. 11/29/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6572506","version":"1","preferredName":"Differentiated and Anaplastic Thyroid Carcinoma American Joint Committee on Cancer Edition 8 Clinical N Category","preferredDefinition":"A clinical finding about one or more characteristics of papillary, follicular, Hurthle cell, poorly differentiated, and anaplastic thyroid carcinoma, following the rules of the TNM AJCC v8 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"6572506v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N1b","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN1b TNM Finding v8","ValueMeaning":{"publicId":"6572508","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN1b TNM Finding v8","longName":"6572508","preferredDefinition":"Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes (levels I, II, III, IV, or V) or retropharyngeal lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN1b TNM Finding v8","conceptCode":"C140908","definition":"Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes (levels I, II, III, IV, or V) or retropharyngeal lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1AEDC-B992-42BF-E053-F662850A427D","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD1AEDC-B9AB-42BF-E053-F662850A427D","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"N1a","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN1a TNM Finding v8","ValueMeaning":{"publicId":"6572510","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN1a TNM Finding v8","longName":"6572510","preferredDefinition":"Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal /Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN1a TNM Finding v8","conceptCode":"C140907","definition":"Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal /Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1AEDC-B9B8-42BF-E053-F662850A427D","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD1AEDC-B9D1-42BF-E053-F662850A427D","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"N1","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN1 TNM Finding v8","ValueMeaning":{"publicId":"6572512","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN1 TNM Finding v8","longName":"6572512","preferredDefinition":"Metastasis to regional nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN1 TNM Finding v8","conceptCode":"C140906","definition":"Metastasis to regional nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1AEDC-B9DE-42BF-E053-F662850A427D","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD1AEDC-B9F7-42BF-E053-F662850A427D","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"N0b","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN0b TNM Finding v8","ValueMeaning":{"publicId":"6572514","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN0b TNM Finding v8","longName":"6572514","preferredDefinition":"No radiologic or clinical evidence of locoregional lymph node metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN0b TNM Finding v8","conceptCode":"C140905","definition":"No radiologic or clinical evidence of locoregional lymph node metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1AEDC-BA04-42BF-E053-F662850A427D","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD1AEDC-BA1D-42BF-E053-F662850A427D","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"N0a","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN0a TNM Finding v8","ValueMeaning":{"publicId":"6572516","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN0a TNM Finding v8","longName":"6572516","preferredDefinition":"One or more cytologically or histologically confirmed benign lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN0a TNM Finding v8","conceptCode":"C140928","definition":"One or more cytologically or histologically confirmed benign lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1AEDC-BA2A-42BF-E053-F662850A427D","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD1AEDC-BA43-42BF-E053-F662850A427D","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"N0","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN0 TNM Finding v8","ValueMeaning":{"publicId":"6572518","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN0 TNM Finding v8","longName":"6572518","preferredDefinition":"No evidence of locoregional lymph node metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN0 TNM Finding v8","conceptCode":"C140904","definition":"No evidence of locoregional lymph node metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1AEDC-BA50-42BF-E053-F662850A427D","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD1AEDC-BA69-42BF-E053-F662850A427D","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"NX","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cNX TNM Finding v8","ValueMeaning":{"publicId":"6572520","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cNX TNM Finding v8","longName":"6572520","preferredDefinition":"Regional lymph nodes cannot be assessed. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cNX TNM Finding v8","conceptCode":"C140903","definition":"Regional lymph nodes cannot be assessed. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1AEDC-BA76-42BF-E053-F662850A427D","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD1AEDC-BA8F-42BF-E053-F662850A427D","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6868429","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma Clinical TNM Finding v8 American Joint Committee on Cancer N Category Category","preferredDefinition":"A clinical finding about one or more characteristics of papillary, follicular, Hurthle cell, poorly differentiated, and anaplastic thyroid carcinoma, following the rules of the TNM AJCC v8 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C140898:C39315:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma Clinical TNM Finding v8","conceptCode":"C140898","definition":"A clinical finding about one or more characteristics of papillary, follicular, Hurthle cell, poorly differentiated, and anaplastic thyroid carcinoma, following the rules of the TNM AJCC v8 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9145A763-91B6-11E7-E053-F662850A6042","latestVersionIndicator":"Yes","beginDate":"2019-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-29","modifiedBy":"ONEDATA","dateModified":"2019-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BD1AEDC-B976-42BF-E053-F662850A427D","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"TAYLORT","dateModified":"2020-04-03","changeDescription":"4/3/20 tmt released. 11/29/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000440","version":"1","longName":"Thyroid","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical N category","type":"Preferred Question Text","description":"Clinical N category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BD42576-B03A-3E4C-E053-F662850A7BA4","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"TAYLORT","dateModified":"2020-04-03","changeDescription":"4/3/20 tmt released.11/29/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}